1. Salhan Sudha
2. Gaikwad Harsha
3. Batra Achla

9789385891793

10.5005/jp/books/12899_46

2/e

2016

6

1. VMMC and Safdarjung Hospital, New Delhi, India, Vardhman Mahavir Medical College and Safdarjung Hospital, Vardhaman Mahavir Medical, College and Safdarjang Hospital, New Delhi, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, VM Medical College and Safdarjung Hospital, New Delhi, Vardhman Mahavir Medical College, New Delhi and Safdarjung Hospital, New Delhi, Safdarjang Hospital, New Delhi, VMMC and Safdarjung Hospital, New Delhi, NDMC Medical College and Hindu Rao Hospital, Delhi
2. VMMC and Safdarjung Hospital, New Delhi, India, VMMC and Safdarjung Hospital, New Delhi, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi

Hemostatic system, coagulation disorders, prothrombin time, fibrin formation, tissue plasminogen activators, urokinase-type plasminogen activators, normal fibrin stabilization, fibrin degradation products, fibrinolytic inhibitors, plasminogen activator inhibitors, thrombophilia, hypercoagulability, consumptive coagulopathy, venous thromboembolism, disseminated intravascular coagulation, platelet thrombi, abruptio placentae, amniotic fluid embolism, intrauterine death, septicemia, pre-eclampsia, pulmonary embolism, deep venous thrombosis, low-molecular weight heparin, Lewenberg\' sign, Homan\'s sign, phlegmasia cerulea dolens, electrocardiogram, indirect thrombin inhibitors, direct thrombin inhibitors, vitamin k antagonist, computerized tomography pulmonary angiogram, unfractionated heparin, synthetic heparin pentasaccharides